Cargando…
Partial response after transcatheter arterial infusion chemotherapy in a patient with systemic chemotherapy-resistant unresectable colon cancer and hepatic metastasis: (case report)
We report here a case of partial response to hepatic arterial infusion chemotherapy in a patient who developed serious hepatic failure due to unresectable colorectal cancer and hepatic metastasis and showed resistance to systemic chemotherapy with molecular targeted drugs, mFOLFOX6, and FOLFIRI. The...
Autores principales: | Sawai, Katsuji, Goi, Takanori, Koneri, Kenji, Katayama, Kanji, Yamaguchi, Akio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3751809/ https://www.ncbi.nlm.nih.gov/pubmed/23957924 http://dx.doi.org/10.1186/1477-7819-11-203 |
Ejemplares similares
-
Five-Year Survival of Alpha-Fetoprotein-Producing Gastric Cancer with Synchronous Liver Metastasis: A Case Report
por: Koneri, Kenji, et al.
Publicado: (2013) -
Hepatic artery infusion therapy is effective for chemotherapy-resistant liver metastatic colorectal cancer
por: Goi, Takanori, et al.
Publicado: (2015) -
Response to Modified TEGAFIRI in a Patient with Synchronous Multiple Liver Metastases of Colon Cancer
por: Takanori, Goi, et al.
Publicado: (2011) -
MUC2 protein expression status is useful in assessing the effects of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of colon cancer
por: FUJISHIMA, YUKA, et al.
Publicado: (2012) -
RPN2 is effective biomarker to predict the outcome of combined chemotherapy docetaxel and cisplatin for advanced gastric cancer
por: Fujimoto, Daisuke, et al.
Publicado: (2018)